URGN - Company ID 0001668243
The table below shows UroGen Pharma Ltd.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $110.75M | $171.99M | $95.00M | $55.41M | $44.36M | $52.86M |
| Short-term investments | $49.31M | $110.67M | $56.16M | - | - | - |
| Receivables | $33.08M | $20.30M | $15.44M | $12.70M | $11.72M | $7.05M |
| Inventory | $16.46M | $9.23M | $5.67M | $4.33M | $4.83M | $1.96M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $186.02M |
| $276.13M |
| $169.19M |
| $128.91M |
| $114.39M |
| $115.62M |
| Property, plant & equipment | $637.00K | $655.00K | $689.00K | $1.30M | $1.97M | $2.05M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $200.46M | $285.71M | $178.31M | $135.62M | $119.75M | $122.00M |
| Accounts payable | $12.14M | $10.93M | $6.51M | $5.53M | $5.79M | $3.27M |
| Total current liabilities | $46.42M | $45.95M | $31.21M | $23.92M | $22.38M | $21.44M |
| Long-term debt | $122.21M | $121.73M | $98.55M | $97.54M | - | - |
| Total liabilities | $305.93M | $294.51M | $243.52M | $224.98M | $111.33M | $25.65M |
| Retained earnings | -$959.72M | -$806.22M | -$679.35M | -$577.10M | -$467.32M | -$356.50M |
| Total equity | -$105.47M | -$8.80M | -$65.21M | -$89.36M | $8.41M | $96.36M |